WHO ICTRP trial

A study on management of subjects with Depression with Siddha drugs Venpoosani…

CTRI/2018/12/016780 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2018/12/016780
Public title A study on management of subjects with Depression with Siddha drugs Venpoosani Nei and Seeraga Thylam
Scientific title Clinical study of Siddha drugs Venpoosani Nei internally and Seeraga Thylam externally in the treatment of Viyakoola Unmaatham (Depression)
Primary sponsor National Institute of Siddha
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries India
Conditions Health Condition 1: F430- Acute stress reaction
Interventions Intervention1: Venpoosani Nei (Internal) and Seeraga Thylam (External): 16 ml of Venpoosani Nei will be administered orally twice a day and 50 ml of Seeraga thylam will be issued for taking oil bath for a period of 48 days. Control…
Registration date Dec 26, 2018
Target size 30
Secondary IDs Nil
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations